Latest Trading on NASDAQ

$3.74
0.81%
(+0.03)
Open 3.75
Previous Close 3.71
Today's Range
3.72 3.76
52 Week Range
3.15 9.00
Volume 25.13K
Avg. Volume (Weekly) 1.69M
Bid 3.73
Ask 3.74
Market Cap 153.05K
EPS -0.78
Shares Outstanding 41.25K
YTD High 9.00
Updated December 3, 2018

Zynerba Pharmaceuticals, Inc.

Overview: Zynerba Pharmaceuticals is a company developing cannabinoid therapies for rare and near-rare neuropsychiatric conditions. The company’s leading drug candidate is a pharmaceutical-grade transdermal...

No data to display.

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates which are in clinical trial stage include ZYN002 and ZYN001 synthetic transdermal cannabinoid therapeutics for indications including refractory epilepsy, Fragile X syndrome, osteoarthritis, fibromyalgia and peripheral neuropathic pain. Zynerba Pharmaceuticals, Inc. is headquartered in Devon, Pennsylvania.